RECRUITING

Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.

Official Title

Quantification of Pain Relief With Gonadal Vein Embolization for Pelvic Congestion Syndrome

Quick Facts

Study Start:2019-05-10
Study Completion:2025-12-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03794466

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Female patients 18 years of age or older
  2. * Meet the clinical and imaging criteria for the diagnosis of PCS and have no contraindications to coil embolization of the gonadal veins.
  3. * Patients who are treated with coil embolization of the gonadal veins in the Interventional Radiology division between October 1, 2018 to October 1, 2019.
  1. * Patients less than 18 years of age.
  2. * Patients who are found to have an underlying cause of pelvic congestion syndrome unrelated to venous congestion and insufficiency. This includes, but is not limited to, nutcracker syndrome, or a mass resulting in extrinsic compression of the gonadal veins.
  3. * Patients who have received prior surgical therapy for PCS, including bilateral salpingo-oophorectomy (TAH-BSO), gonadal vein resection, or gonadal vein ligation.

Contacts and Locations

Study Contact

Carissa Walter, MPH
CONTACT
9139457450
cwalter2@kumc.edu

Principal Investigator

Adam S Alli, MD
PRINCIPAL_INVESTIGATOR
The University of Kansas Medical Center

Study Locations (Sites)

The University of Kansas Medical Center
Kansas City, Kansas, 66160
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

  • Adam S Alli, MD, PRINCIPAL_INVESTIGATOR, The University of Kansas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-05-10
Study Completion Date2025-12-15

Study Record Updates

Study Start Date2019-05-10
Study Completion Date2025-12-15

Terms related to this study

Keywords Provided by Researchers

  • gonadal vein embolization

Additional Relevant MeSH Terms

  • Pelvic Congestive Syndrome
  • Pelvic Pain